Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

R Furlan, S Krishnan, J Vietri - Patient preference and adherence, 2015 - Taylor & Francis
Introduction New longer-acting factor products will potentially allow for less frequent infusion
in prophylactic treatment of hemophilia. However, the role of administration frequency …
被引用次数：48 相关文章
[HTML] nih.gov

[HTML][HTML] Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

R Furlan, S Krishnan, J Vietri - Patient preference and adherence, 2015 - ncbi.nlm.nih.gov
Aim To identify the relative importance of frequency of administration, efficacy, and other
treatment characteristics among candidates for prophylactic treatment for hemophilia A and …

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia.

R Furlan, S Krishnan, J Vietri - Patient Preference and Adherence, 2015 - europepmc.org
Aim To identify the relative importance of frequency of administration, efficacy, and other
treatment characteristics among candidates for prophylactic treatment for hemophilia A and …

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia.

R Furlan, S Krishnan, J Vietri - Patient Preference & …, 2015 - search.ebscohost.com
Introduction: New longer-acting factor products will potentially allow for less frequent
infusion in prophylactic treatment of hemophilia. However, the role of administration …

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

R Furlan, S Krishnan, J Vietri - Patient Preference and Adherence, 2015 - go.gale.com
Introduction: New longer-acting factor products will potentially allow for less frequent
infusion in prophylactic treatment of hemophilia. However, the role of administration …

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

R Furlan, S Krishnan, J Vietri - Patient Preference and Adherence, 2015 - dovepress.com
Aim: To identify the relative importance of frequency of administration, efficacy, and other
treatment characteristics among candidates for prophylactic treatment for hemophilia A and …

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

R Furlan, S Krishnan, J Vietri - Patient preference and …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction New longer-acting factor products will potentially allow for less frequent infusion
in prophylactic treatment of hemophilia. However, the role of administration frequency …